Royce & Associates’s Alvotech ALVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06M Buy
+558,144
New +$2M 0.02% 608
2025
Q4
Sell
-124,346
Closed -$1.02M 764
2025
Q3
$1.02M Sell
124,346
-148,728
-54% -$1.27M 0.01% 665
2025
Q2
$2.49M Buy
273,074
+102,031
+60% +$958K 0.03% 570
2025
Q1
$1.65M Buy
171,043
+12,043
+8% +$146K 0.02% 617
2024
Q4
$2.1M Buy
159,000
+28,000
+21% +$345K 0.02% 623
2024
Q3
$1.56M Buy
131,000
+37,000
+39% +$429K 0.01% 662
2024
Q2
$1.14M Buy
+94,000
New +$1.26M 0.01% 701

Other funds holding ALVO

Royce & Associates's ALVO Position: Q2 2026 in Review

Royce & Associates opened a new position in Alvotech (ALVO) in Q2 2026: 558,144 shares worth $2.06M. The stake represents 0.02% of the portfolio and ranks #608 among its holdings. This is a return to the name: Royce & Associates previously reported a position in ALVO as recently as Q3 2025.

Royce & Associates first reported a position in ALVO in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.49M in Q2 2025. 65 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

  • Royce & Associates held 558,144 shares of Alvotech worth $2.06M as of Q2 2026.
  • Alvotech was a new Royce & Associates position in Q2 2026.
  • Alvotech made up 0.02% of Royce & Associates's portfolio in Q2 2026, its #608 holding.
  • Royce & Associates first reported a position in Alvotech in Q2 2024 and has held it in 7 quarters since.
  • Royce & Associates's Alvotech position peaked at $2.49M in Q2 2025.
  • 65 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.